FMC Corporation has announced the regulatory approval of its Tremisia® fungicide in Ukraine, marking the first introduction of the company's novel fluindapyr technology in the European, Middle East, and Africa (EMEA) region. The approval covers over 10 million hectares of farmland, specifically targeting crops such as oilseed rape, sunflower, and wheat. Tremisia® fungicide, which combines the proprietary fluindapyr molecule with flutriafol, offers a dual mode of action against a broad spectrum of significant crop diseases. This development follows successful commercialization efforts in countries like Argentina, Brazil, and the United States, with further expansions anticipated in regions such as Bolivia and India.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FMC Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: PH21548) on June 30, 2025, and is solely responsible for the information contained therein.